Alterity Therapeutics Files 6-K, Incorporates into Registration Statements
Ticker: PRNAF · Form: 6-K · Filed: Jul 21, 2025 · CIK: 1131343
| Field | Detail |
|---|---|
| Company | Alterity Therapeutics Ltd (PRNAF) |
| Form Type | 6-K |
| Filed Date | Jul 21, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: registration-statement, securities-filing, procedural
Related Tickers: ATH
TL;DR
Alterity Therapeutics (ATH) filed a 6-K, linking it to existing S-8 and F-3 filings for security quotes.
AI Summary
Alterity Therapeutics Limited filed a Form 6-K on July 21, 2025, to incorporate by reference into its existing Registration Statements on Form S-8 and Form F-3. The filing includes an application for quotation of securities under the ticker ATH.
Why It Matters
This filing is procedural, indicating Alterity Therapeutics is updating or maintaining its registration statements, which is necessary for the issuance of securities under those statements.
Risk Assessment
Risk Level: low — This is a routine administrative filing and does not appear to contain new material financial or operational information.
Key Players & Entities
- Alterity Therapeutics Limited (company) — Registrant
- ATH (company) — Ticker symbol for securities
- Form S-8 (document) — Registration Statement type
- Form F-3 (document) — Registration Statement type
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is being incorporated by reference into Alterity Therapeutics Limited's existing Registration Statements on Form S-8 and Form F-3.
What specific exhibit is included with this filing?
Exhibit 99.1 is an 'Application for quotation of securities - ATH'.
What is the principal executive office address of Alterity Therapeutics Limited?
The principal executive office is located at Level 14, 350 Collins Street, Melbourne, Victoria 3000, Australia.
Does Alterity Therapeutics file annual reports under Form 20-F or Form 40-F?
Yes, Alterity Therapeutics indicates it files annual reports under Form 20-F.
What is the ticker symbol associated with the securities application in Exhibit 99.1?
The ticker symbol is ATH.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 21, 2025 regarding ALTERITY THERAPEUTICS LTD (PRNAF).